Literature DB >> 467566

Abnormal visual pathways in human albinos studied with visually evoked potentials.

J Coleman, C F Sydnor, M L Wolbarsht, M Bessler.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 467566     DOI: 10.1016/0014-4886(79)90052-9

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  8 in total

1.  The clinical features of albinism and their correlation with visual evoked potentials.

Authors:  S E Dorey; M M Neveu; L C Burton; J J Sloper; G E Holder
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

2.  What was the matter with Dr Spooner?

Authors:  B Jay
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

3.  Component specificity in albino VEP asymmetry: maturation of the visual pathway anomaly.

Authors:  P Apkarian; D Reits; H Spekreijse
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

4.  Ocular findings in the Hermansky-Pudlak syndrome.

Authors:  N J Izquierdo; W Townsend; I E Hussels
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Optokinetic, vestibular, and optokinetic-vestibular responses in albino and pigmented rats.

Authors:  J Lannou; L Cazin; W Precht; M Toupet
Journal:  Pflugers Arch       Date:  1982-03       Impact factor: 3.657

Review 6.  [Abnormal representations in the visual cortex of patients with albinism: diagnostic aid and model for the investigation of the self-organisation of the visual cortex].

Authors:  M B Hoffmann; L C Schmidtborn; A B Morland
Journal:  Ophthalmologe       Date:  2007-08       Impact factor: 1.059

7.  Albinism in childhood: a flash VEP and ERG study.

Authors:  I Russell-Eggitt; A Kriss; D S Taylor
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

8.  Distribution of macular ganglion cell layer thickness in foveal hypoplasia: A new diagnostic criterion for ocular albinism.

Authors:  Viktoria C Brücher; Peter Heiduschka; Ulrike Grenzebach; Nicole Eter; Julia Biermann
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.